Notice of Change to Eligibility of Foreign Components and Requirement for Letter of Support for PAR-21-109, "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
Notice Number:
NOT-AG-21-017

Key Dates

Release Date:

February 8, 2021

Related Announcements

PAR-21-109 - Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)

Issued by

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Purpose

This Notice informs applicants of changes to the Foreign Institutions Eligibility information and letter of support requirement for Project/Performance Site Location in Funding Opportunity Announcement (FOA) PAR-21-109, "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)".

Effective immediately, the following sections of PAR-21-109, "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)" have been modified, as indicated below.

Currently Reads:

Part 2. Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statementare not allowed. 

Part 2. Section IV. Application and Submission Information

2. Content and Form of Application Submission

SF424(R&R) Project/Performance Site Location

All instructions in the SF424 (R&R) Application Guide must be followed.

Modified to Read (changes shown in bold italics):

Part 2. Section III. Eligibility Information

1. Eligible Applicants

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Part 2. Section IV. Application and Submission Information

2. Content and Form of Application Submission

SF424(R&R) Project/Performance Site Location

All instructions in the SF424 (R&R) Application Guide must be followed. Applications should include a letter of support from the home/host institution, indicating availability of NHP-related facilities and infrastructure for the proposed project, as evidence for its feasibility.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Manuel Moro, DVM, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-480-1796
Email: manuel.moro@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices